Hims & Hers Health, Inc. (NYSE:HIMS) Insider Michael Chi Sells 7,259 Shares

Hims & Hers Health, Inc. (NYSE:HIMS) insider Michael Chi sold 7,259 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $43.28, for a total value of $314,169.52. Following the sale, the insider now owns 193,601 shares in the company, valued at approximately $8,379,051.28. This represents a 3.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Michael Chi also recently made the following trade(s):

• On Friday, January 24th, Michael Chi sold 17,304 shares of Hims & Hers Health stock. The shares were sold at an average price of $31.00, for a total value of $536,424.00.
• On Friday, January 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The shares were sold at an average price of $24.07, for a total value of $174,724.13.
• On Tuesday, December 24th, Michael Chi sold 17,303 shares of Hims & Hers Health stock. The shares were sold at an average price of $27.97, for a total value of $483,964.91.
• On Thursday, December 19th, Michael Chi sold 7,500 shares of Hims & Hers Health stock. The shares were sold at an average price of $26.00, for a total value of $195,000.00.
• On Tuesday, December 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The shares were sold at an average price of $32.25, for a total value of $234,102.75.
• On Monday, December 2nd, Michael Chi sold 2,054 shares of Hims & Hers Health stock. The shares were sold at an average price of $33.56, for a total value of $68,932.24.

Hims & Hers Health Stock Performance

Shares of HIMS stock opened at $43.56 on Wednesday. Hims & Hers Health, Inc. has a 52-week low of $9.14 and a 52-week high of $46.01. The firm has a market capitalization of $9.52 billion, a PE ratio of 99.01 and a beta of 1.35. The stock has a fifty day simple moving average of $30.73 and a two-hundred day simple moving average of $23.58.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on HIMS shares. BTIG Research started coverage on Hims & Hers Health in a report on Tuesday, January 7th. They set a “buy” rating and a $35.00 price target on the stock. TD Cowen reissued a “buy” rating and set a $28.00 price target on shares of Hims & Hers Health in a report on Wednesday, November 20th. Piper Sandler raised their target price on Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Citigroup cut Hims & Hers Health from a “neutral” rating to a “sell” rating and raised their target price for the stock from $24.00 to $25.00 in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $25.13.

Institutional Investors Weigh In On Hims & Hers Health

A number of institutional investors have recently bought and sold shares of the business. Creative Planning purchased a new position in shares of Hims & Hers Health during the second quarter valued at about $443,000. Sanctuary Advisors LLC purchased a new position in shares of Hims & Hers Health during the second quarter valued at about $415,000. CWM LLC grew its position in shares of Hims & Hers Health by 21.4% during the third quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after purchasing an additional 1,054 shares in the last quarter. Carnegie Investment Counsel purchased a new position in shares of Hims & Hers Health during the third quarter valued at about $5,531,000. Finally, nVerses Capital LLC grew its position in shares of Hims & Hers Health by 31.8% during the third quarter. nVerses Capital LLC now owns 14,100 shares of the company’s stock valued at $260,000 after purchasing an additional 3,400 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.